Selenium biomarkers in prostate cancer cell lines and influence of selenium on invasive potential of PC3 cells

Frontiers in Oncology

Volumn 3 SEP, Issue , 2013, Pages

  Hendrickx, Wouter ^a   Decock, Julie ^b   Mulholland, Francis ^c   Bao, Yongping ^a   Fairweather Tait, Susan ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

Biomarkers; GPx; Invasion; Prostate cancer; Selenium; TrxR1

Indexed keywords

GLUTATHIONE PEROXIDASE 1; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 18; SELENIUM; THIOREDOXIN REDUCTASE 1; VASCULOTROPIN;

ARTICLE; BIOPSY; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME ACTIVITY; GLEASON SCORE; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84891085573     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00239     Document Type: Article

References (37)

1. Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, et al. Selenium in human health and disease. Antioxid Redox Signal (2011) 14(7):1337-83. doi:10.1089/ars.2010.3275
2. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal (2007) 9(7):775-806. doi:10.1089/ars.2007.1528
3. Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, et al. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr (2012) 96(1):111-22. doi:10.3945/ajcn.111.033373
4. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, et al. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of L-selenomethionine: a Southwest Oncology Group study. Clin Cancer Res (2006) 12(7 Pt 1):2178-84. doi:10.1158/1078-0432.CCR-05-0937
5. Takata Y, Morris JS, King IB, Kristal AR, Lin DW, Peters U. Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue. Prostate (2009) 69(15):1635-42. doi:10.1002/pros.21012
6. Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, et al. Selenium and vitamin E: cell type-and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst (2009) 101(5):306-20. doi:10.1093/jnci/djn512
7. Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol (1999) 150(4):367-74. doi:10.1093/oxfordjournals.aje.a010016
8. Cai W, Deng JY, Ouyang B, Li P, Li F, Zhou DY, et al. Surveillance on Keshan disease from 1990 to 2008 in Sichuan province. Zhonghua Liu Xing Bing Xue Za Zhi (2009) 30(8):820-3.
9. Sunde RA, Raines AM, Barnes KM, Evenson JK. Selenium status highly regulates selenoprotein mRNA levels for only a subset of the selenoproteins in the selenoproteome. Biosci Rep (2009) 29(5):329-38. doi:10.1042/BSR20080146
10. Cheng W, Fu YX, Porres JM, Ross DA, Lei XG. Selenium-dependent cellular glutathione peroxidase protects mice against a pro-oxidant-induced oxidation of NADPH, NADH, lipids, and protein. FASEB J (1999) 13(11):1467-75.
11. Lu J, Holmgren A. Selenoproteins. J Biol Chem (2009) 284(2):723-7. doi:10.1074/jbc.R800045200
12. Karunasinghe N, Ferguson LR, Tuckey J, Masters J. Hemolysate thioredoxin reductase and glutathione peroxidase activities correlate with serum selenium in a group of New Zealand men at high prostate cancer risk. J Nutr (2006) 136(8):2232-5.
13. Yoon SO, Kim MM, Chung AS. Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem (2001) 276(23):20085-92. doi:10.1074/jbc.M101143200
14. Zeng H, Briske-Anderson M, Idso JP, Hunt CD. The selenium metabolite methylselenol inhibits the migration and invasion potential of HT1080 tumor cells. J Nutr (2006) 136(6):1528-32.
15. Yan L, Frenkel GD. Inhibition of cell attachment by selenite. Cancer Res (1992) 52(20):5803-7.
16. Rooprai HK, Kyriazis I, Nuttall RK, Edwards DR, Zicha D, Aubyn D, et al. Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol (2007) 30(5):1263-71.
17. Song H, Kim J, Lee HK, Park HJ, Nam J, Park GB, et al. Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression. Int Immunopharmacol (2011) 11(12):2208-13. doi:10.1016/j.intimp.2011.10.002
18. Xiang N, Zhao R, Zhong W. Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells. Cancer Chemother Pharmacol (2009) 63(2):351-62. doi:10.1007/s00280-008-0745-3
19. Kandas Nö, Randolph C, Bosland MC. Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations. Nutr Cancer (2009) 61(2):251. doi:10.1080/01635580802398430
20. Menter DG, Sabichi AL, Lippman SM. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev (2000) 9(11):1171-1182.
21. Sinha R, Pinto JT, Facompre N, Kilheffer J, Baatz JE, El-Bayoumy K. Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells. Nutr Cancer (2008) 60(2):267-75. doi:10.1080/01635580701630479
22. Ip C, Thompson HJ, Zhu Z, Ganther HE. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res (2000) 60(11):2882-6.
23. Pinto JT, Sinha R, Papp K, Facompre ND, Desai D, El-Bayoumy K. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. Int J Cancer (2007) 120(7):1410-7. doi:10.1002/ijc.22500
24. Yang X, Tian Y, Ha P, Gu L. Determination of the selenomethionine content in grain and human blood. Wei Sheng Yan Jiu (1997) 26(2):113-6.
25. Cai XJ, Block E, Uden PC, Zhang X, Quimby BD, Sullivan JJ. Allium chemistry: identification of selenoamino acids in ordinary and selenium-enriched garlic, onion, and broccoli using gas chromatography with atomic emission detection. J Agric Food Chem (1995) 43(7):1754-7. doi:10.1021/jf00055a001
26. Schrauzer GN. Nutritional selenium supplements: product types, quality, and safety. J Am Coll Nutr (2001) 20(1):1-4. doi:10.1080/07315724.2001.10719007
27. Nève J. Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol (1995) 9(2):65-73. doi:10.1016/S0946-672X(11)80013-1
28. Rebsch CM, Penna FJ, Copeland PR. Selenoprotein expression is regulated at multiple levels in prostate cells. Cell Res (2006) 16(12):940-8. doi:10.1038/sj.cr.7310117
29. Jerome-Morais A, Wright ME, Liu R, Yang W, Jackson MI, Combs GF Jr, et al. Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue. Prostate (2011) 72(9):1006-12. doi:10.1002/pros.21506
30. Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res (2003) 23(3B):2425-33.
31. Shi C, Yu L, Yang F, Yan J, Zeng H. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun (2003) 309(3):578-83. doi:10.1016/j.bbrc.2003.08.032
32. Karlenius TC, Shah F, Yu WC, Hawkes HJ, Tinggi U, Clarke FM, et al. The selenium content of cell culture serum influences redox-regulated gene expression. Biotechniques (2011) 50(5):295-301.
33. Jung K, Seidel B, Rudolph B, Lein M, Cronauer MV, Henke W, et al. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic Biol Med (1997) 23(1):127-33. doi:10.1016/S0891-5849(96)00613-2
34. Barrera LN, Cassidy A, Johnson IT, Bao Y, Belshaw NJ. Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention. Proc Nutr Soc (2012) 71(2):237-45. doi:10.1017/S002966511200016X
35. Lim HW, Hong S, Jin W, Lim S, Kim SJ, Kang HJ, et al. Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells. Exp Mol Med (2005) 37(5):497-506. doi:10.1038/emm.2005.62
36. Carlson BA, Yoo MH, Sano Y, Sengupta A, Kim JY, Irons R, et al. Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression. BMC Immunol (2009) 10:57. doi:10.1186/1471-2172-10-57
37. Ehrbar M, Sala A, Lienemann P, Ranga A, Mosiewicz K, Bittermann A, et al. Elucidating the role of matrix stiffness in 3D cell migration and remodeling. Biophys J (2011) 100(2):284-93. doi:10.1016/j.bpj.2010.11.082